Record-breaking 'dead' galaxy discovered by JWST lived fast and died young in the early universe
When you buy through links on our articles, Future and its syndication partners may earn a commission.
Using the James Webb Space Telescope (JWST), astronomers have found the most distant (and thus the earliest) massive "dead" galaxy to date. The discovery suggests that galaxies were "dying" much earlier in the universe than previously believed.
"Death" for a galaxy refers to the slowing down, or even halting, of intense star formation, which stops a galaxy from growing. Such dead galaxies are more formally referred to as being "quiescent," or "quenched." Early dead galaxies seen by the JWST have been referred to as "red and dead" galaxies due to their lack of massive hot young blue stars and their abundance of old small red stars. They have also been dubbed "Little Red Dots" due to their appearance in JWST images.
Light from this new record-breaking galaxy, designated RUBIES-UDS-QG-z7, has been traveling to us for 13 billion years, meaning the JWST saw it as it was just 700 million years after the Big Bang. That makes it the first so-called massive quiescent galaxy (MQG) seen in the infancy of the 13.8 billion-year-old universe.
"We discovered a galaxy which formed 15 billion times the mass of the sun in stars and then stopped forming stars before the universe was only 700 million years old," team member Andrea Weibel of the University of Geneva (UNIGE) Department of Astronomy told Space.com. "This makes RUBIES-UDS-QG-z7 the most distant massive quiescent galaxy known to date."
The discovery may challenge our models of how galaxies evolve — and eventually stop growing — due to the cessation of star birth.
"The observation implies that some galaxies have stopped forming stars when the universe was only 700 million years old," Weibel said. "So far, models and simulations contain very few such objects, more than 100 times fewer than the existence of RUBIES-UDS-QG-z7 suggests. This means that the physical processes and mechanisms that regulate star formation and its termination in galaxies in the early universe may have to be revisited."
Quiescent galaxies are common immediately around the Milky Way. That's expected because the further away we look, the further back in time we are traveling. Thus, local massive galaxies have had a lot of time to start forming stars, grow to tremendous masses, and then exhaust the gas and dust needed for stellar construction, thus becoming quenched. We should expect more distant galaxies to still be enjoying their star-birthing youth.
As the JWST has probed further and further back in time, however, it has discovered earlier and earlier MQGs. Several of these red and dead galaxies were found as early as 1.2 billion years after the Big Bang. Discovered as part of the "Red Unknowns: Bright Infrared Extragalactic Survey," or RUBIES, program, RUBIES-UDS-QG-z7 pushes the detection of MQGs back by another 500 million years.
"Massive galaxies observed early in the universe only had a very limited amount of time to form their stars. This means they must have formed rapidly and efficiently, which helps us to constrain and, in some cases, even challenge theories and models of galaxy formation and growth," Weibel said. "RUBIES-UDS-QG-z7, however, is not only massive but has already stopped forming stars 50 to 100 million years before we observe it, while normal galaxies at these epochs are still building up their stellar mass through star formation."
Weibel explained that the mass of RUBIES-UDS-QG-z7 and its reconstructed formation history suggest relatively efficient star formation for the galaxy. That does not directly challenge existing models of star formation.
"The galaxy is very compact and may be an example of an object where a lot of gas and dust — the fuel of star formation — collapses and assembles into a small volume, where stars can form rapidly and efficiently for an extended period of time, or in multiple bursts," Weibel said. "What makes RUBIES-UDS-QG-z7 stand out is that it stopped forming stars so early on."
This MQG may stand out from Little Red Dots seen by the JWST in ways other than its rapid death.
"In the JWST images, RUBIES-UDS-QG-z7 resembled objects named Little Red Dots, which have been discovered with the JWST," Weibel said. "Many of these objects turned out to have strong emission lines and/or showed signs of active galactic nuclei (AGN). Thus, at least a good fraction of the light we observe from Little Red Dots may actually originate from accreting supermassive black holes, rather than stars."However, Weibel added that RUBIES-UDS-QG-z7 shows no signs of an AGN, meaning its light comes entirely from stars, not from the violent conditions around a feeding black hole.
"This then implies its rather high mass and its quiescence, which both came as a big surprise," Weibel continued. "So far, we have only found one such object in all the JWST data that we investigated."
From this, the team calculated that galaxies like RUBIES-UDS-QG-z7 should account for around one in 1 million galaxies.
"This is, however, quite uncertain, because we don't know how lucky we got to find one in the small patch of the sky that we have scanned so far," Weibel said. "With hopefully many more years of JWST taking data, we will be able to search larger areas of the sky and get a better idea of how common galaxies like RUBIES-UGD-QG-z7 actually are."
Related Stories:
— Is our universe trapped inside a black hole? This James Webb Space Telescope discovery might blow your mind
—James Webb Space Telescope finds our Milky Way galaxy's supermassive black hole blowing bubbles (image, video)
— James Webb Space Telescope sees early galaxies defying 'cosmic rulebook' of star formation
Performing higher resolution and deeper spectroscopy imaging of this galaxy could reveal the abundances of various elements, which would help better constrain the formation history of RUBIES-UDS-QG-z7.
"We will get more data on this galaxy in the upcoming Cycle 4 of JWST observations. Specifically, higher resolution spectroscopy," Weibel said.The JWST may need a helping hand to study RUBIES-UDS-QG-z7 from Earth's largest radio telescope project, the Atacama Large Millimeter/submillimeter Array (ALMA), which consists of 66 antennas located in the Atacama Desert region of Northern Chile."Data from the ALMA telescope at longer wavelengths of light can give us direct insight into the gas and dust content of the galaxy, which is closely related to its past and future star formation history," Weibel said.
The team's research was published on April 1 in The Astrophysical Journal.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
NASA's Parker Solar Probe spots powerful magnetic explosion aimed at the sun's surface
When you buy through links on our articles, Future and its syndication partners may earn a commission. While making a death-defying dive through the sun's atmosphere, NASA's Parker Solar Probe has directly recorded a powerful plasma explosion heading toward our star's surface in unprecedented detail. Parker's new measurements found protons with about 1000 times greater energy than expected and a plasma jet shooting toward the sun, not away from it. Parker was uniquely positioned between the sun and the particles' source, allowing scientists to easily figure out where they came from. These findings indicate that the complexity and strength of tangles in the sun's magnetic field can accelerate charged particles to much greater speeds than expected from the field's strength alone. The sunward plasma jet was caused by "magnetic reconnection" in the sun's atmosphere — the explosive process in which magnetic fields fracture and reconnect. The powerful phenomenon transforms energy stored in the sun's magnetic field into energy that accelerates the solar wind — the constant stream of charged particles that the sun blasts across the solar system. Understanding magnetic reconnection is critical for making better predictions about space weather, which is driven by the solar wind and other energetic outbursts from our star. Space weather is a primary suspect for what stripped away Mars' atmosphere, turning it from a habitable planet into an icy desert wasteland. On Earth, space weather can trigger geomagnetic storms that cause blackouts, damage satellites, interfere with radio and GPS signals, and even put astronauts at risk. On the bright side, it also gives Earth its signature glorious auroras. The sun's magnetic field is extremely powerful, complex and dynamic. Space weather predictions require complicated computer simulations based on equations that describe how magnetic fields behave — but the sun is so large and convoluted that these equations will always be approximations. To improve the models' accuracy, scientists must collect extremely detailed measurements of the sun. This is where the Parker Solar Probe comes in. The Parker Solar Probe is the first mission to fly into the sun's upper atmosphere, called the corona. It has been directly measuring magnetic fields and particles in and around the corona in unprecedented detail, providing scientific insight into the heliosphere (the sun's atmosphere, which encompasses the entire solar system in a massive, elongated bubble). Related: NASA's daredevil solar spacecraft survives 2nd close flyby of our sun "These findings indicate that magnetic reconnection … is an important source of energetic particles in the near-Sun solar wind," lead study author Mihir Desai, director of the Southwest Research Institute's Department of Space Research, said in a statement. "Everywhere there are magnetic fields there will be magnetic reconnection. But the Sun's magnetic fields are much stronger near the star, so there's a lot more stored energy to be released." Understanding the workings of magnetic reconnection events could help scientists better predict harmful space weather, the researchers said. RELATED STORIES —New 8K-resolution photos of the sun show off incredible details of raging sunspots —Space photo of the week: Pink 'raindrops' on the sun captured in greatest detail ever —Powerful Mother's Day geomagnetic storm created radio-disrupting bubbles in Earth's upper atmosphere "Reports from the American Meteorological Society indicated that the powerful solar events in May 2024 wreaked havoc with farmers when extreme geomagnetic storms disrupted the precise GPS-guided navigation systems used to plant, fertilize and harvest rows of seeds, causing an estimated loss of up to $500 million in earning potential," Desai said. "Parker's access to this new data is critical, particularly as we remain in the midst of a very active solar cycle." The latest measurements of magnetic reconnection, reported in a paper published May 29 in The Astrophysical Journal Letters, are one of many new discoveries Parker has made. In 2023, over 700 peer-reviewed scientific papers were published using data collected in the probe's first four years of operation, and there are still many more discoveries to be made. The spacecraft completed its second ultra-close flyby of the sun on March 22, zooming within 3.8 million miles (6.1 million kilometers) of the sun's surface — matching its own record from December 2024.
Yahoo
11 hours ago
- Yahoo
See the moon shine with famous red star Antares in the southern sky on June 9
When you buy through links on our articles, Future and its syndication partners may earn a commission. The waxing gibbous moon will shine close to the red star Antares in the constellation Scorpius on the night of June 9. Stargazers in the U.S. will find the moon rising higher over the southeastern horizon after sunset on June 9, with Antares shining brightly around 4 degrees to the lower left of the lunar disk. For context, your little finger held at arms length accounts for roughly 1 degree in the night sky, while your index, middle and ring fingers together amount to around 5 degrees, according to NASA. Antares is also known as the "Heart of the Scorpion" thanks to its prominent position in the zodiacal constellation Scorpius, which itself contains a number of stunning deep sky objects, such as the Messier 4 globular cluster and the closest stellar nursery to Earth — Rho Ophiuchi. As a red supergiant, Antares boasts a diameter 700 times greater than our sun and is known to shine roughly 10,000 times brighter. It is expected to end its life in a dramatic supernova explosion when it runs out of fuel — an event that could happen anytime from tomorrow to a million years or so from now. The lunar disk will appear to close in on Antares as the night of June 9 progresses, with the red star eventually setting above the moon's upper left shoulder as the duo slip beneath the southwestern horizon in the predawn hours of June 10. Viewers based in a number of southern hemisphere countries, including Australia, Tasmania and Papua New Guinea, will see the moon slide directly in front of Antares, blocking its light in an event known as an '"occultation" starting at 4:47 a.m. EDT (0847 GMT), according to Stargazers hoping to capture the majesty of the lunar surface should check out our handy guide detailing how to photograph the moon, while those looking for a closer view of the cosmos should read our lists of the best telescopes and binoculars for exploring the night sky. Editor's Note: If you happen to capture a picture of the moon and Antares and want to share it with readers, then please send your photo(s), comments, and your name and location to spacephotos@
Yahoo
11 hours ago
- Yahoo
HIV/AIDS: Facts about the viral infection that attacks the immune system
When you buy through links on our articles, Future and its syndication partners may earn a commission. QUICK FACTS ABOUT HIV What it is: A lifelong viral infection that weakens the immune system, if left untreated Prevention methods: Taking preventive medicines called PrEP, using condoms, and avoiding needle sharing Treatments: Medicines called antiretroviral therapy (ART) Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help people reach lifespans of near-normal length. However, when people don't have access to those medicines, HIV infections progress to an advanced stage called acquired immunodeficiency syndrome (AIDS), which is fatal within about three years if not treated. When a person has AIDS, most of their key, disease-fighting immune cells are lost. This loss of immune protection leaves the person vulnerable to deadly infections and cancers. Although an HIV diagnosis was once a death sentence, scientists have developed treatments that suppress the virus and enable people to live long lives without transmitting the disease to others. Additionally, there are now effective preventive medications that can dramatically reduce the risk of getting HIV in the first place. There is not yet a widespread cure for HIV/AIDS, although a handful of people have been cured of the infection or are in long-term remission thanks to special stem-cell transplants, specially cell transplants from people who have genes that make them resistant to the virus. Scientists are exploring potential avenues for a cure, which could someday mean that people who contract HIV could be rid of the infection rather than having to take medication for life to manage the disease. HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the end of 2023. Around 630,000 people died from illnesses related to AIDS the same year; by weakening the immune system, AIDS opens the door to these fatal diseases. HIV can spread through contact with an infected person's bodily fluids, although it's important to note that not all bodily fluids can transmit the virus. Bodily fluids that can spread HIV include blood, semen, preseminal fluid, vaginal secretions, breastmilk and rectal discharge (liquid from the anus that's not blood or stool). HIV is not transmitted through saliva, sweat or tears. It's also not spread through the air or through casual contact, such as hugging, shaking hands or sharing food. For transmission to occur, the bodily fluids containing HIV must come into contact with mucous membranes — tissues that line cavities in the body, like the vagina, anus or mouth. The fluids can also transmit HIV when they come into contact with cuts or sores, or when they're introduced to the bloodstream via contaminated needles, for instance. Most people who contract HIV get it through unprotected anal or vaginal sex — meaning sex without a condom or without HIV-preventing medications. People can also contract the virus by sharing the equipment used to inject drugs, such as needles or syringes. Babies can get HIV in the womb, during childbirth or from breastfeeding, if their mother has HIV. People living with HIV who take medicines called ART can suppress the virus to the point that it can't spread via sex. These "virally suppressed" people also have a much lower chance of transmitting HIV to their kids via pregnancy, childbirth or breastfeeding. They are also less likely to spread the virus via shared injection equipment, although experts aren't sure exactly how much the risk is reduced. The symptoms of HIV vary depending on how far the disease has progressed. The virus can spread from one person to another at any stage of the infection, unless the infected person is taking ART and has reached "viral suppression" (see glossary). The initial stage is called "acute HIV infection." Within two to four weeks of contracting the virus, many people develop a flu-like illness involving symptoms like fever, headache, rash and sore throat. These symptoms can last from a few days to a few weeks. Some people have no symptoms at this stage, however. The viral load, or amount of HIV in the blood, at this stage is very high. The second stage of the disease is "chronic HIV infection," during which the virus continues to multiply but at a slower speed than during acute infection. This stage is also called "clinical latency" or "asymptomatic HIV infection," as many people don't feel sick during it. People can remain in this stage of the disease for 10 to 15 years, though some pass through it more quickly. As the virus multiplies, levels of an important type of immune cell — CD4 T lymphocytes — decline. Without treatment, the disease will eventually enter its most advanced stage: AIDS. This can come with a wide range of symptoms, including rapid weight loss; recurring fever; night sweats; extreme tiredness; prolonged swelling of the lymph nodes; diarrhea; sores of the mouth, anus or genitals; and blotches on or under the skin or inside the mouth, nose or eyelids. It can also trigger neurological problems, like memory loss. AIDS raises the risk of severe bacterial infections and cancers, including lymphomas and Kaposi's sarcoma. It can also worsen viral infections, such as hepatitis B and mpox. Without any treatment, people with AIDS typically survive about three years. HIV and AIDS are related, in that AIDS is the most advanced stage of an HIV infection, and therefore, the HIV virus causes both conditions. AIDS can also be called a "stage 3 HIV infection." AIDS is defined in part by a very low CD4 count of fewer than 200 CD4 cells per cubic millimeter (mm3) of blood. Generally speaking, the CD4 counts of healthy teens and adults are around 500 to 1,200 cells/mm3. Anything below 500 cells/mm3 is considered low, and 200 cells/mm3 marks the threshold for an AIDS diagnosis. Doctors also diagnose AIDS by considering a patient's history of "AIDS-defining illnesses." These are medical conditions often seen in people with AIDS because their immune systems can't fight the illnesses off. They include "opportunistic" infections — those caused by germs that wouldn't necessarily harm a person with a well-functioning immune system. Such infections include a fungal infection called extrapulmonary cryptococcosis, recurrent blood infections with Salmonella bacteria, the parasitic infection toxoplasmosis, and lower respiratory infections caused by the herpes simplex virus. The bacterial disease tuberculosis poses a major risk to people with AIDS, and it is currently the leading cause of death for people living with HIV/AIDS worldwide. AIDS-defining illnesses also include cancers such as Kaposi's sarcoma, Burkitt's lymphoma and invasive cervical cancer. Others include HIV encephalopathy, which affects brain function, and HIV wasting syndrome, which causes extreme weight loss and weakness. Complications of AIDS-defining illnesses raise the risk of death, but the degree of risk varies among diseases. At all three stages of the infection, HIV is treated with antiretroviral therapy (ART) — combinations of medications that drive down the amount of HIV in the blood. Different ART drugs work in different ways to keep the amount of virus, or viral load, in check. They are available as daily pills or as shots given periodically throughout the year, depending on the person's treatment plan. It's key for patients to take their medication as prescribed, because missing pills or shots can open the door for the virus to multiply, as well as develop drug resistance, which causes the medication to work less well. ART medications can also interact with other drugs and carry some risk of serious side effects, so patients work with their medical providers to figure out which drug combination is best for them. The goal of ART is "viral suppression," which describes when a person's viral load falls low enough that there are 200 or fewer copies of the virus's genetic material per milliliter (mL) of blood. Historically, tests weren't sensitive enough to detect levels of HIV below that threshold, so doctors called this level "undetectable." Studies also found that people who reach viral suppression can't transmit the virus via sex; have a lower chance of spreading the virus through pregnancy, childbirth or breastfeeding; and likely have a lower chance of spreading it through needle sharing. This is why the slogan "undetectable equals untransmittable," or "U = U," was coined. Nowadays, some tests for HIV are extremely sensitive, so they can detect viral loads significantly below 200 copies/mL. However, experts emphasize that 200 copies/mL is still the critical threshold at which transmission risk becomes extremely low. If a person with HIV/AIDS develops another medical condition, such as an AIDS-defining illness, the individual would receive treatment for that condition in addition to their ART regimen. There is no widespread cure for HIV/AIDS. However, a handful of people have been cured of their HIV infections through stem cell transplants, and a few more are considered "potentially" cured via the same process. Stem cells can develop into different types of cells in the body. In certain cancers that affect blood cells, stem cell transplants can be used to replace the cells lost in the course of cancer treatments such as chemotherapy. Each individual who has been cured of HIV also had one of these cancers, so their doctors searched for stem cell donors who carry a rare gene that makes them resistant to HIV infection. By swapping in cells from an HIV-resistant individual, the procedure essentially locks the virus out of the patient's CD4 cells. There is one exception to this rule: A person known as the "Geneva patient" was potentially cured of HIV after a stem cell transplant, but the donor didn't have this special genetic resistance. It's unclear exactly why the man entered long-term remission from the infection after this procedure, but scientists are investigating. There have also been a couple of cases in which people's own immune systems somehow rallied against the virus and controlled it without treatment; these people are known as "elite controllers." Scientists hope to learn from both the stem cell recipients and from elite controllers to discover cures that could reach far more people with HIV/AIDS. Meanwhile, some researchers are exploring the use of gene-editing tools like CRISPR to cure the infection, while others are investigating the use of drugs and modified immune cells. Antiretroviral therapy (ART) – Combinations of medications that lower the amount of HIV in a person's blood. These drugs, given as pills or shots, prevent the viral infection from progressing to AIDS and dramatically lower a person's risk of complications and of transmitting the virus to others. Pre-exposure prophylaxis (PrEP) – Medicines that people at risk of being exposed to HIV take to prevent the infection. Viral load – The amount of HIV in a person's blood. This is measured in terms of the number of HIV RNA molecules — the virus's genetic material — found in a milliliter of blood. It's an important way to measure how well ART is working. Viral suppression – When a person's viral load falls to 200 copies/mL or lower. Viral suppression is the goal of ART, as it both lowers a person's likelihood of spreading the virus and extends their lifespan by preventing the infection from progressing to AIDS. CD4 T lymphocyte – A type of white blood cell that helps coordinate the actions of other immune cells to fight infections. HIV infects CD4 cells and uses them to multiply while the virus depletes the number of CD4 cells in the body. Image 1 of 4 In the 1980s and 1990s, groups organized "die-ins" to protest the lack of U.S. government attention to the ongoing HIV/AIDS crisis. Die-ins were also conducted to push for support for research to uncover effective treatments and, once treatments were discovered, to demand that those drugs be released to the public. The AIDS Coalition to Unleash Power — known as ACT UP — was a major force behind such protests and remains an active organization today. Image 2 of 4 Kaposi's sarcoma, an example of an AIDS-defining illness, characteristically causes big, purple patches or nodules to appear on the skin and mucous membranes. Image 3 of 4 The public health slogan "U = U," depicted on this sign, refers to the fact that people living with HIV who have undetectable viral loads cannot transmit the virus to others via sex. It stands for "undetectable = untransmittable." Image 4 of 4 The "Berlin patient," pictured here, was the first person cured of HIV via a stem cell transplant. His name was later revealed to be Timothy Ray Brown. Brown went on to launch a foundation under his name that was dedicated to fighting HIV/AIDS. We could end the AIDS epidemic in less than a decade. Here's how. In a 1st, HIV vaccine triggers rare and elusive antibodies in humans Nearly 3 million extra deaths by 2030 could result from HIV funding cuts, study suggests
